Group 1: FIGS (FIGS) - FIGS is a direct-to-consumer healthcare apparel and lifestyle brand with a Zacks Rank 1 (Strong Buy) [1] - The Zacks Consensus Estimate for FIGS's current year earnings increased by 83.3% over the last 60 days [1] - FIGS's shares gained 71.9% over the last three months compared to the S&P 500's gain of 5.1% [1] - The company possesses a Momentum Score of A [1] Group 2: Okeanis Eco Tankers Corp. (ECO) - Okeanis Eco Tankers is an international tanker company providing seaborne transportation of crude oil and refined products, with a Zacks Rank 1 [2] - The Zacks Consensus Estimate for Okeanis Eco Tankers' current year earnings increased by 66.3% over the last 60 days [2] - Okeanis Eco Tankers' shares gained 32.8% over the last three months compared to the S&P 500's gain of 5.1% [2] - The company possesses a Momentum Score of A [2] Group 3: United Natural Foods (UNFI) - United Natural Foods is the leading distributor of natural, organic, and specialty food and non-food products in the U.S. and Canada, with a Zacks Rank 1 [3] - The Zacks Consensus Estimate for United Natural Foods' current year earnings increased by 7.4% over the last 60 days [3] - United Natural Foods' shares gained 21% over the last three months compared to the S&P 500's gain of 5.1% [3] - The company possesses a Momentum Score of A [3]

Core Insights - Five stocks have been added to the Zacks Rank 1 (Strong Buy) List, indicating strong potential for investment Group 1: Company Performance - FIGS (FIGS) has seen a significant increase in the Zacks Consensus Estimate for its current year earnings, rising by 83.3% over the last 60 days [1] - MongoDB (MDB) has experienced a 27% increase in the Zacks Consensus Estimate for its current year earnings over the past 60 days [1] - Kennametal (KMT) has had a 25% increase in the Zacks Consensus Estimate for its current year earnings in the last 60 days [2] - EverQuote (EVER) has seen a 12.2% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - OppFi (OPFI) has experienced a 10.6% increase in the Zacks Consensus Estimate for its current year earnings in the past 60 days [3]

Core Insights - Three stocks with strong momentum and a Zacks Rank 1 are highlighted for investors: Lumentum Holdings Inc., FIGS, Inc., and Everus Construction Group, Inc. [1][2][3] Company Summaries - **Lumentum Holdings Inc. (LITE)**: - Zacks Consensus Estimate for current year earnings increased by 11.1% over the last 60 days - Shares gained 108.7% over the last three months, while the S&P 500 declined by 5.8% - Momentum Score of A [1] - **FIGS, Inc. (FIGS)**: - Zacks Consensus Estimate for current year earnings increased by 33.3% over the last 60 days - Shares gained 36.4% over the past three months, compared to the S&P 500's decline of 5.9% - Momentum Score of A [2] - **Everus Construction Group, Inc. (ECG)**: - Zacks Consensus Estimate for current year earnings increased by 11.6% over the last 60 days - Shares gained 38.0% over the last three months, while the S&P 500 declined by 5.9% - Momentum Score of A [3]

Core Insights - The article emphasizes an active investing strategy focused on identifying breakout stocks within specific price ranges, recommending to sell if prices drop below the lower boundary and to hold for gains if they surpass the upper boundary [1] Breakout Stock Identification - To identify breakout stocks, it is essential to calculate support and resistance levels, where support is the lower bound and resistance is the upper bound for stock movements [2] - Demand for a stock is lowest at its support level, while traders are more inclined to buy at the resistance level, making it crucial to focus on stocks nearing a breakout or those that have just surpassed resistance [3] Validating Breakouts - A genuine breakout occurs when the previous resistance level becomes the new support level, which can be confirmed through long-term price trend analysis [5] - The strength of support and resistance levels is determined through such studies, and correctly identifying breakout stocks can lead to significant returns [5] Screening Criteria - The screening criteria for breakout stocks include: - A percentage price change over four weeks between 10% and 20% [6] - Current price to 52-week high ratio greater than or equal to 0.9 [6] - Zacks Rank of less than or equal to 2 [6] - Beta for 60 months less than or equal to 2 [7] - Current price less than or equal to $20 [7] - These criteria narrow down the stock universe from over 6,853 to only 12 potential candidates [7] Featured Breakout Stocks - Orla Mining Ltd. (ORLA) focuses on acquiring, exploring, and developing mineral properties, with an expected earnings growth rate of 212% for the current year and a Zacks Rank of 2 [9] - FIGS, Inc. (FIGS) operates as a direct-to-consumer healthcare apparel company, with an expected earnings growth rate of 400% for the current year and a Zacks Rank of 1 [10] - Compass Therapeutics, Inc. (CMPX) is a clinical-stage oncology biopharmaceutical company with an expected earnings growth rate of 16.7% for the next quarter and a Zacks Rank of 2 [11]

Company Overview - FIGS, Inc. produces and sells scrubs and scrubwear for healthcare professionals in the United States and globally [1] - The company sells its items online and through select retail stores, referred to as community hubs [1] Investment Approach - A holistic investment approach is taken that considers both top-down and bottom-up valuation techniques [1] - Detailed analysis of companies, including capital structure and debt covenants, is emphasized as playing a significant role in equity valuation [1]

Company Overview - FIGS, Inc. produces and sells scrubs and scrubwear for healthcare professionals in the United States and globally [1] - The company sells its items online and through select retail stores, referred to as community hubs [1] Investment Approach - A holistic investment approach is taken that considers both top-down and bottom-up valuation techniques [1] - Detailed analysis of companies, including capital structure and debt covenants, is emphasized as playing a significant role in equity valuation [1]

Core Insights - Healthcare apparel company Figs reported Q3 CY2025 revenue of $151.7 million, an 8.2% year-on-year increase, exceeding analyst estimates of $142.5 million [1][5] - The company achieved a non-GAAP profit of $0.05 per share, significantly above the consensus estimate of $0.02 [1][5] - Adjusted EBITDA reached $18.85 million, with a margin of 12.4%, surpassing analyst expectations of $12.38 million [5] Management Commentary - Management attributed the strong performance to consistent execution across core products and disciplined promotional strategies, leading to higher average order values and customer engagement [3][4] - CEO Trina Spear highlighted broad-based growth in scrubwear and the U.S. market, along with improvements in product fit and returns processing [3] - The company plans to maintain momentum through increased inventory investments, new product introductions, and targeted international growth, including the launch of FIBERx fabric at the 2026 Winter Olympics [3] Financial Performance - Operating margin improved to 6.4%, up from -6.2% in the same quarter last year [5] - Active customers increased to 2.78 million, representing a year-on-year growth of 108,000 [5] - Market capitalization stands at $1.23 billion [5] Strategic Initiatives - The deliberate reduction in promotional activity led to higher average order values and improved profitability, with more sales occurring at full price [6] - Growth was primarily driven by the core scrubwear category, with new silhouettes and improved fits reducing return rates [6] - Figs expanded its international presence from 33 to nearly 60 markets, with recent launches in Japan and South Korea, and an upcoming debut in China [6] Product Development - Non-scrubwear categories, including underscrubs, compression socks, and footwear, saw renewed momentum due to targeted product launches [6] - Operational efficiency gains were achieved through supply chain optimization and reduced marketing expenses, despite facing higher tariffs on imports [6]

Financial Performance - Net revenues reached $1517 million, reflecting an 8% year-over-year growth[32,34] - Gross margin stood at 699%[32] - Adjusted EBITDA margin was 124%, exceeding expectations[32,34] - International net revenues grew by 12%[34] Key Operating Metrics - Average order value (AOV) increased by 6% to $114[34] - Active customers grew by 4% to 28 million[34] - Net revenues per active customer increased 2%[41] Strategic Initiatives - Expanding to nearly 60 countries outside the U S by the end of 2025[51,75] - FIGS donated $100000 to The Bluebird Center for Healthcare Education and Access[71] - FIGS donated $50000 to F Cancer[71] Updated Outlook for 2025 - Net revenues are expected to increase approximately 70% compared to 2024[125] - Adjusted EBITDA margin is expected to be around 103%[126]

Healthcare apparel company Figs (NYSE:FIGS) reported Q3 CY2025 results exceeding the market’s revenue expectations , with sales up 8.2% year on year to $151.7 million. Its non-GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates. Is now the time to buy Figs? Find out in our full research report. Figs (FIGS) Q3 CY2025 Highlights: Revenue: $151.7 million vs analyst estimates of $142.5 million (8.2% year-on-year growth, 6.4% beat) Adjusted EPS: $0.05 vs analyst estimates of ...

Core Insights - Baron Focused Growth Fund reported a 4.83% appreciation in Q3 2025, underperforming the Russell 2500 Growth Index's 10.73% gain due to economic growth concerns affecting Consumer Discretionary stocks and rising competitive pressures [1] Company Highlights - FIGS, Inc. (NYSE:FIGS) achieved a one-month return of 9.22% and a 52-week gain of 13.64%, closing at $7.58 per share with a market capitalization of $1.238 billion on November 5, 2025 [2] - In Q3 2025, FIGS, Inc. shares increased by 18.6%, contributing 35 basis points to the fund's performance, driven by strong results and revenue acceleration from recent investments despite reduced promotions [3] - The company is experiencing improved purchasing patterns and margin enhancements due to better efficiency from its new fulfillment center, positioning itself to capture market share in the $80 billion global healthcare apparel industry [3] - FIGS is expected to grow its core scrubs business while expanding into retail stores, business-to-business revenue, and international markets, supported by revenue acceleration and strong cash generation [3]